(Q44902367)

English

Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study

scientific article published on September 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

0 references

Elizabeth Barrett-Connor

1

object named as

Elizabeth Barrett-Connor

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Paul Miller

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Ya-Ting Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Lois E. Wehren

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501602

12 March 2024

Ethel S. Siris

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501602

12 March 2024

Thomas A. Abbott

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501602

12 March 2024

Marc L. Berger

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501602

12 March 2024

Arthur C. Santora

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501602

12 March 2024

Louis M. Sherwood

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501602

12 March 2024

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

full work available at URL

https://journals.lww.com/10.1097/01.GME.0000086467.82759.DA

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

412-419

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Prevention of osteoporosis

1

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss

2

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women

3

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

5

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale

6

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease

7

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Postmenopausal bone loss at multiple skeletal sites: relationship to estrogen use.

8

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

The effect of postmenopausal estrogen therapy on bone density in elderly women

9

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

10

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study

11

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Effects of current and discontinued estrogen replacement therapy on hip structural geometry: the study of osteoporotic fractures

12

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Bone response to termination of oestrogen treatment

13

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Bone mass after withdrawal of oestrogen replacement

14

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

15

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study

16

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial

17

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers

18

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment

20

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

24

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women

25

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

27

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Prevention of spinal osteoporosis in oophorectomised women

29

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women

31

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Hormone replacement therapy: benefit, risk and cost considerations

32

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Intervention thresholds for osteoporosis

34

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

36

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Fractures and lifestyle: effect of cigarette smoking, alcohol intake, and relative weight on the risk of hip and forearm fractures in middle-aged women

37

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Milk, dietary calcium, and bone fractures in women: a 12-year prospective study

38

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment

39

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Axial and appendicular bone density predict fractures in older women

40

1 reference

10.1097/01.GME.0000086467.82759.DA

https://api.crossref.org/works/10.1097/01.GME.0000086467.82759.DA

12 March 2024

Identifiers

10.1097/01.GME.0000086467.82759.DA

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44902367&oldid=2100132703"